Reply to: Comments on “Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)”

Reply to: Comments on “Toxicity‐related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune‐based combinations (ARON‐1 study)” / Molina‐Cerrillo, Javier; Roviello, Giandomenico; Fiala, Ondrej; Taha, Tarek; Buti, Sebastiano; Rizzo, Mimma; Massari, Francesco; Monteiro, Fernando Sabino Marques; Santoni, Matteo. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - STAMPA. - 158:(2026), pp. 1992-1994. [10.1002/ijc.70289]

Reply to: Comments on “Toxicity‐related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune‐based combinations (ARON‐1 study)”

Roviello, Giandomenico;
2026

Abstract

Reply to: Comments on “Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)”
2026
158
1992
1994
Molina‐Cerrillo, Javier; Roviello, Giandomenico; Fiala, Ondrej; Taha, Tarek; Buti, Sebastiano; Rizzo, Mimma; Massari, Francesco; Monteiro, Fernando Sa...espandi
File in questo prodotto:
File Dimensione Formato  
Molina‐Cerrillo et al. Int J of Cancer, 2026.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 295.99 kB
Formato Adobe PDF
295.99 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1452157
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact